These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 2240363)
1. Immunization of owl monkeys with a combination of Plasmodium falciparum asexual blood-stage synthetic peptide antigens. Ruebush TK2nd ; Campbell GH; Moreno A; Patarroyo ME; Collins WE Am J Trop Med Hyg; 1990 Oct; 43(4):355-66. PubMed ID: 2240363 [TBL] [Abstract][Full Text] [Related]
2. Immunogenicity and efficacy trials in Aotus nancymai monkeys with model compounds representing parts of a 75-kD merozoite surface antigen of Plasmodium falciparum. Sharma P; Ruebush TK; Campbell GH; Richman SJ; Wilkins PP; Broderson JR; Ardeshir F; Gross M; Silverman C; Skinner JC Am J Trop Med Hyg; 1992 Jun; 46(6):691-707. PubMed ID: 1621894 [TBL] [Abstract][Full Text] [Related]
3. Immunogenicity of the Plasmodium falciparum asexual blood-stage synthetic peptide vaccine SPf66. Millet P; Campbell GH; Sulzer AJ; Grady KK; Pohl J; Aikawa M; Collins WE Am J Trop Med Hyg; 1993 Mar; 48(3):424-31. PubMed ID: 7682382 [TBL] [Abstract][Full Text] [Related]
4. Studies in owl monkeys leading to the development of a synthetic vaccine against the asexual blood stages of Plasmodium falciparum. Rodriguez R; Moreno A; Guzman F; Calvo M; Patarroyo ME Am J Trop Med Hyg; 1990 Oct; 43(4):339-54. PubMed ID: 2240362 [TBL] [Abstract][Full Text] [Related]
5. Protection of Aotus monkeys after immunization with recombinant antigens of Plasmodium falciparum. Enders B; Hundt E; Knapp B Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():413-22. PubMed ID: 1343721 [TBL] [Abstract][Full Text] [Related]
6. Protection of Aotus monkeys from malaria infection by immunization with recombinant hybrid proteins. Knapp B; Hundt E; Enders B; Küpper HA Infect Immun; 1992 Jun; 60(6):2397-401. PubMed ID: 1587607 [TBL] [Abstract][Full Text] [Related]
7. Induction of protective immunity against experimental infection with malaria using synthetic peptides. Patarroyo ME; Romero P; Torres ML; Clavijo P; Moreno A; Martínez A; Rodríguez R; Guzman F; Cabezas E Nature; 1987 Aug 13-19; 328(6131):629-32. PubMed ID: 3302727 [TBL] [Abstract][Full Text] [Related]
8. Immunization of owl monkeys with the ring-infected erythrocyte surface antigen of Plasmodium falciparum. Collins WE; Anders RF; Ruebush TK; Kemp DJ; Woodrow GC; Campbell GH; Brown GV; Irving DO; Goss N; Filipski VK Am J Trop Med Hyg; 1991 Jan; 44(1):34-41. PubMed ID: 1996739 [TBL] [Abstract][Full Text] [Related]
9. Renal pathology in owl monkeys vaccinated with Plasmodium falciparum asexual blood-stage synthetic peptide antigens. Nagatake T; Broderson JR; Tegoshi T; Collins WE; Aikawa M Am J Trop Med Hyg; 1992 Nov; 47(5):614-20. PubMed ID: 1449202 [TBL] [Abstract][Full Text] [Related]
10. Immunization trials with the ring-infected erythrocyte surface antigen of Plasmodium falciparum in owl monkeys (Aotus vociferans). Collins WE; Pappaioanou M; Anders RF; Campbell GH; Brown GV; Kemp DJ; Broderson JR; Coppel RL; Skinner JC; Procell PM Am J Trop Med Hyg; 1988 Mar; 38(2):268-82. PubMed ID: 3281493 [TBL] [Abstract][Full Text] [Related]
11. A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malaria. Patarroyo ME; Amador R; Clavijo P; Moreno A; Guzman F; Romero P; Tascon R; Franco A; Murillo LA; Ponton G Nature; 1988 Mar; 332(6160):158-61. PubMed ID: 2450281 [TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and protective efficacy of affinity-purified Plasmodium falciparum exoantigens in Aotus nancymai monkeys. James MA; Fajfar-Whetstone CJ; Kakoma I; Buese MM; Clabaugh GW; Hansen R; Ristic M Trop Med Parasitol; 1991 Mar; 42(1):49-54. PubMed ID: 2052857 [TBL] [Abstract][Full Text] [Related]
13. Protective immunity induced in Aotus monkeys by a recombinant SERA protein of Plasmodium falciparum: further studies using SERA 1 and MF75.2 adjuvant. Inselburg J; Bathurst IC; Kansopon J; Barr PJ; Rossan R Infect Immun; 1993 May; 61(5):2048-52. PubMed ID: 8478093 [TBL] [Abstract][Full Text] [Related]
14. Failure of a synthetic vaccine to protect Aotus lemurinus against asexual blood stages of Plasmodium falciparum. Herrera S; Herrera MA; Corredor A; Rosero F; Clavijo C; Guerrero R Am J Trop Med Hyg; 1992 Nov; 47(5):682-90. PubMed ID: 1449209 [TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of four Plasmodium falciparum preerythrocytic antigens in Aotus lemurinus monkeys. Perlaza BL; Arévalo-Herrera M; Brahimi K; Quintero G; Palomino JC; Gras-Masse H; Tartar A; Druilhe P; Herrera S Infect Immun; 1998 Jul; 66(7):3423-8. PubMed ID: 9632616 [TBL] [Abstract][Full Text] [Related]
16. Efficiency of human Plasmodium falciparum malaria vaccine candidates in Aotus lemurinus monkeys. Herrera S; Herrera MA; Certa U; Corredor A; Guerrero R Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():423-8. PubMed ID: 1343722 [TBL] [Abstract][Full Text] [Related]
17. A recombinant hybrid protein as antigen for an anti-blood stage malaria vaccine. Knapp B; Hundt E; Enders B; Küpper HA Behring Inst Mitt; 1991 Feb; (88):147-56. PubMed ID: 2049032 [TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and in vivo efficacy of recombinant Plasmodium falciparum merozoite surface protein-1 in Aotus monkeys. Kumar S; Yadava A; Keister DB; Tian JH; Ohl M; Perdue-Greenfield KA; Miller LH; Kaslow DC Mol Med; 1995 Mar; 1(3):325-32. PubMed ID: 8529111 [TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys. Burns JM; Miura K; Sullivan J; Long CA; Barnwell JW Malar J; 2016 Mar; 15():159. PubMed ID: 26975721 [TBL] [Abstract][Full Text] [Related]